This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ucb Biopharma Sprl. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Brendon Mackenzie: Innovator in Antibody Development
Introduction
Brendon Mackenzie is a notable inventor based in Slough, GB. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of neutralising antibodies.
Latest Patents
Mackenzie holds a patent for "Neutralising antibodies to the major exotoxins TCDA and TCDB." This invention describes the derivation and selection of antibodies capable of neutralising the major exotoxins, TcdA and TcdB. The patent also highlights the novel neutralisation and antigen binding properties of individual monoclonal antibodies (Mabs) and mixtures thereof. He has 1 patent to his name.
Career Highlights
Brendon Mackenzie is currently employed at UCB Biopharma Sprl, where he continues to advance research in antibody development. His work focuses on innovative solutions to combat bacterial toxins, contributing to the broader field of immunology.
Collaborations
Mackenzie collaborates with esteemed colleagues, including David Paul Humphreys and Daniel John Lightwood, to enhance the research and development of therapeutic antibodies.
Conclusion
Brendon Mackenzie is a dedicated inventor whose work in neutralising antibodies is paving the way for advancements in biopharmaceuticals. His contributions are vital to the ongoing fight against bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile